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Abstract
Background: It is important to monitor health related quality of life in order to determine the efficacy of
interventions and physical functioning of patients with cystic fibrosis in their daily activities. There is no a single-
item global quality of life scale for routine clinical practice for adult patients with cystic fibrosis. We assessed the
reliability and validity of a single-item global quality of life scale and compared with the Cystic Fibrosis Quality of
Life Questionnaire (CF-QOL) for adult patients with cystic fibrosis.
Method: 121 (men = 66, women = 55) adult cystic fibrosis patients self-completed the CF-QOL, the Hospital
Anxiety Depression Scale, and the single item global quality of life scale at the out patient clinic. 33 (17 women)
completed the repeat questionnaires at home within two weeks. Socio-demographic characteristic and lung
function data were extracted from the recent medical notes.
Results: Mean (SD) age was 29.6 (8.9) years and mean (SD) forced expiratory volume in 1 second was 2.20 (0.94)
litres. The test-retest reproducibility using the intra-class correlation coefficient (ICC) for the CF-QOL was 0.83, 95%
confidence interval 0.68 to 0.91. The single item global quality of life ICC score was 0.78, 95% confidence interval
0.59 to 0.88. Concurrent validity of the single-item global quality of life was examined in relation to all items of the
CF-QOL, frequent episodes of readmission, anxiety and depression (all, p < 0.01) were moderately correlated.
Conclusion: The study provides preliminary evidence that the single-item quality of life scale is acceptable, valid
and repeatable for adult patients with cystic fibrosis. It is a promising tool that can be easily incorporated into a
routine clinical practice to assess patients’ quality of life.
Keywords: Quality of life, single-item global scale, cystic fibrosis, reliability, concurrent validity, adult, HRQOL, CF-
QOL
Introduction
There are disease-specific validated health related quality
of life (HRQOL) scales [1,2] that measure dimensions of
health, not otherwise assessed by conventional lung
function tests in order to determine the severity of the
disease for adult patients with cystic fibrosis (CF).
HRQOL scales are regarded as relevant endpoints to
measure the efficacy of clinical drug trials and the bene-
fits of rehabilitation for adult CF patients [3,4]. They
also provide additional information that is specific to an
individual and not captured, for example, by lung func-
tion tests or other endpoints.
HRQOL scales provide the overall impact of the dis-
ease and to gain further insight from the patients’ per-
spective. The most commonly used disease-specific
HRQOL scales for patients with cystic fibrosis are the
Cystic Fibrosis Quality of Life Scale (CF-QOL) with 52
items with eight quality of life domains [1] and the Cys-
tic Fibrosis Questionnaire Revised (CFQ-R) with 50
items with nine quality of life domains and three symp-
tom scales [2]. They are valid and responsive tools (to
therapeutic interventions) for measuring quality of life
in both clinical and research studies [1,2]. However, the
* Correspondence: A.yohannes@mmu.ac.uk
1Department of Health Professions, Research Institute for Health and Social
Change, Manchester Metropolitan University, Elizabeth Gaskell Campus,
Hathersage Road, M13 0JA, UK
Full list of author information is available at the end of the article
Yohannes et al. Health and Quality of Life Outcomes 2011, 9:105
http://www.hqlo.com/content/9/1/105
© 2011 Yohannes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
HRQOL scales are time-consuming and difficult to
incorporate as a routine ‘health status’ tool for clinical
practice. This is partly due to the comprehensive nature
of the questionnaires. The average time to complete an
HRQOL questionnaire for an adult CF patient is
between 15 to 20 minutes [1,2]. The global scale (self-
rated health status scale) has been used in other condi-
tion, for example, in patients with chronic obstructive
pulmonary disease, to monitor patient’s condition, and
to predict future episodes of acute exacerbation and
hospital readmission [5]. It takes a couple of minutes to
complete. There is often very little time available in a
busy outpatient clinic for adult CF patients to complete
lengthy questionnaires and for the health care profes-
sionals’ to supervise questionnaire completion.
We hypothesise that a single-item global quality of life
scale may be potentially useful for routine clinical prac-
tice in outpatient settings for adult patients with cystic
fibrosis. A reliable and valid single-item global quality of
life scale is desirable because of its brevity. In addition
self-completing by the patient avoids disrupting the flow
of routine clinical care. It will also provide an alternative
and/or complement the existing HRQOL scales for
researchers and clinicians.
The rationale behind assessing the single item global
scale in relation to the CF-QOL was to determine its
psychometric property and the repeatability of the scale
within two periods of time, in order to quantify the sen-
sitivity and specificity of the scale. In addition, there are
no ‘gold standard’ criteria to validate the single item glo-
bal quality of life scale for adult patients with cystic
fibrosis. Depressive and anxiety symptoms are common
in adult CF patients [6]. We broadly hypothesised that a
valid single-item global scale is most likely to relate to
negative or positive psychological well-being (anxiety
and depression) in adult CF patients. If our hypothesis
is true then the lower score in the single item global
quality of life scale (poorer global quality of life score)
will be associated with impaired or poorer quality of life
measured by CF-QOL [2] and with elevated levels of
depressive and anxiety symptoms assessed by the Hospi-
tal Anxiety and Depression scale (HAD) scale [7].
We assessed the feasibility of administration the test-
retest reliability and the validity of a single-item global
quality of life scale. We also examined the relationship
of the single item global quality of life scale with the
disease-specific Cystic Fibrosis Quality of Life question-
naire (CF-QOL) [1], anxiety, depression and lung func-
tion with adult patients with cystic fibrosis.
Methods
Sample selection and procedures
Details of the methodology and other related data have
been reported elsewhere [8]. Briefly, adult cystic fibrosis
patients over 18 years of age were recruited from those
attending routine outpatient clinics at a referral centre
of the University teaching hospital, which covers the
whole of the North-West of England. Participants were
included if they had a confirmed diagnosis of CF and
were able to read and speak English. Patients who were
experiencing acute exacerbation or who had been
admitted to hospital in the previous six-weeks were
excluded. Lung function and other relevant data were
extracted from the latest medical notes. The study pro-
tocol was approved by the local research ethics commit-
tee and all subjects gave informed consent to participate
in the study.
The adult CF patients who provided informed consent
were invited to complete the HAD scale [7], the CF-
QOL [1] and single item global quality of life scale in
the outpatient CF clinic. The researcher randomly admi-
nistered the questionnaires, supervised completion and
provided appropriate support when required.
The test-retest reliability of a measure is an estimate
of its reproducibility over time when no change in con-
dition has taken place. After ten days interval, all the
outcome measures were sent by post with a pre-paid
envelope to examine the test-retest reliability of the sin-
gle-item global quality of life scale. All adult CF patients
that completed the baseline outcome measures in outpa-
tient clinic were sent the repeat questionnaires. An advi-
sory letter was also sent to ensure that the health status
of the adult CF patients was stable during this period. If
they had an exacerbation, participants were advised not
to complete the questionnaires.
Measures
Adult CF patients rated their health status using a self-
completed a single item global quality of life scale (with
a barometer anchored, from 0 - ‘the worst it has ever
been’ to 10 - ‘the best it has ever been’) over the last 2
weeks, see Figure 1. The subjects were shown in a verti-
cal line scale with the numbers ranged from 0 to 10,
with increments of 1. They were asked to rate the num-
ber that described the overall perception of their
HRQOL. Lower scores on the single global quality of
life scale indicate higher impact on adult CF patients’
HRQOL.
Depression and anxiety in adult CF patients was mea-
sured by the HAD scale [7], which consists of 14 items
(seven for anxiety and seven for depression). Each item
is scored 0 to 3, with a maximum score of 21. It has
established clinical cut-off scores: 0 to 7 normal symp-
tom levels, 8 to 10 probable depressive or anxiety symp-
toms and ≥ 11 clinically-elevated for anxiety or
depression [7,9]. The HAD scale has demonstrated
excellent psychometric property of internal consistency
coefficients (cronbach alpha) 0.78 for the anxiety sub-
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domain and 0.79 for the depression sub-domain [6,7].
The sensitivity and specificity of the HAD depressive or
anxiety symptoms (at a cut off score ≥ 8, for each sub-
domain) has been demonstrated above 0.80 in
indentifying those with symptoms compared without
symptoms [9].
The HRQOL was examined using a 52 item CF-QOL
scale [1] across 9 domains of physical functioning, social
Figure 1 The single item global quality of life scale for adult patients with cystic fibrosis.
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functioning, treatment issues, chest symptoms, emo-
tional functioning, concerns about the future, interper-
sonal relationships, body image and carer concerns.
Response choices are ranged with a possible difficulty
on a 6-point scale for performing an activity (e.g. I have
had difficulty doing physical jobs. 1 = all of the time to
6 = never). Scores are standardised on a 0 to 100-point
for each domain, with higher scores corresponding to
better quality of life. The scale also gives an average
aggregate score for all the domains. The internal consis-
tency of the domains of the CF-QOL has been demon-
strated with Cronbach alpha coefficients ranging
between 0.72 - 0.92 [1]. The test-retest reliability of the
CF-QOL for all domains is between (r = 0.74 to 0.96)
[1]. The physical functioning domain of the CF-QOL
demonstrated strong predictor of survival in patients
with cystic fibrosis [10].
Data analysis
Descriptive statistics such as percentages, means, med-
ians, standard deviations and range were used where
appropriate. The repeatability of the single-item quality
of life scale and CF-QOL were assessed by the intra-
class correlation coefficient [11] and limits of agreement
[12]. We employed the conventional interpretation of
the inter-class correlation coefficient: i.e. those values of
0.40 - 0.75 are fair to good and values over 0.75 are
excellent [13]. The concurrent validity of the single item
global scale was examined in relation to anxiety, depres-
sion, lung function and the domains of CF-QOL using
Pearson Correlation coefficient tests. Differences
between the groups of adult CF patients who did and
did not complete the second assessment were examined
using the Student t-test, the Mann-Whitney U-test and
the chi-square test as appropriate. We examined the
area under the receiver operator characteristic curve to
assess the discriminative ability of a single-item global
quality of life scale in relation to the CF-QOL scale and
calculated sensitivity and specificity values. Significance
was set at the conventional 5% level.
Results
Patient population
One-hundred twenty one adult cystic fibrosis patients
(66 men and 55 women) completed the baseline mea-
surements. Their mean (SD) age was 29.6 (8.9) years
and mean FEV1(SD) was 2.20 (0.94) litres. Of these, 33
cystic fibrosis patients (17 women) completed the post-
two-weeks measurement. The mean (SD) age in the
group retested was 32.0 (10.2) years compared to 28.6
(8.2) years in those adult CF patients who were not
retested.
Figure 1 shows the single item global quality of life
scale for adult patients with cystic fibrosis.
Figure 2 shows the distribution of the single-item
score at baseline.
Representativeness of the sample with repeat measures
There are no statistically significant differences between
age, gender, single item score, health related quality of
life, anxiety and depression those who completed (n =
33) the single item and those who did not respond (n =
88) the repeatability questionnaires see Table 1.
Repeatability for single item global scale (baseline versus
2 weeks)
The Intra-class correlation coefficient for the single item
global scale was 0.78; 95% CI (0.59 to 0.88). The mean
difference between the two readings (2nd-1st reading):
-0.1; 95% limits of agreement = -2.5 to 2.3. Hence the
discrepancy between two readings could be as large as
36% (= 2.5/6.9). Of the 33 subjects, 18 (55%) had identi-
cal readings, 28 (85%) had readings with a discrepancy
of 1 or less. The greatest discrepancy (for one subject)
was 4.
Repeatability for CF-QOL (baseline versus 2 weeks)
The intra-class correlation coefficient for the CF-QOL
was = 0.83; 95% CI (0.68 to 0.91). The mean difference
between the two readings was (2nd-1st reading): 1.4; 95%
limits of agreement = -15.1 to 17.9. The discrepancy
between the two readings could be as large as 25% (=
17.9/72). Of the 33 subjects, 21 (64%) had readings with
a discrepancy of 5 or less, 27 (82%) had readings with a
discrepancy of 10 or less. The greatest discrepancy (for
1 subject) was 25.
Concurrent validity of the single item global quality of
life scale
Table 2 shows the correlation of the single item global
scale with CF-QOL domains, anxiety and depression
and with forced expiratory volume in one second
(FEV1). Most of the CF-QOL variables were moderately
correlated (r = 0.38 - 0.61, p < 0.001) with the single
item global scale. The single-item global scale was
weakly correlated with FEV1 and body image (r = 0.21
and r = 0.25, p = 0.01, respectively). Higher scores with
the single-item global scale was correlated negatively
with anxiety (r = -0.50, p < 0.001), depression (r = -0.38,
p < 0.001) and frequency of hospital readmission in the
previous year (r = -0.39, p < 0.001).
Sensitivity and specificity of a single item global quality
of life scale
Figure 3 shows the predictive ability of a single-item
scale related to a health related quality of life score >
50. One-hundred and seven (88%) subjects had a CF-
QOL score > 50. The optimal threshold for a single
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item global scale for score 5 or more showed sensitivity
= 93% (100/107), 95% confidence interval (87% to 97%)
and specificity 64% (9/14), 95% confidence interval (39%
to 84%). The likelihood ratio for a positive test (LR+)
was 2.6; 95% confidence interval (1.3 to 5.3). Increasing
the threshold of a single item global scale by 1 point to
6 or more reduced the sensitivity to 82% (88/107) and
increased the specificity to 78% (11/14). The area under
the ROC curve was 0.84.
Figure 4 shows the predictive ability of a single item
scale related to a health related quality of life score >
80. Forty-three (33%) of subjects had a CF-QOL score >
80. The optimal threshold for a single item for score 7
or more showed sensitivity = 87% (40/46), 95% confi-
dence interval (74% to 94%) and specificity = 53% (40/
75), 95% confidence interval (42% to 64%). The likeli-
hood ratio for a positive test (LR+) was 1.9; 95% confi-
dence interval (1.4 to 2.4). Increasing the threshold of a
single item global scale by 1 point to 8 or more, the
sensitivity value reduced to 70% (32/46), and the specifi-
city value increased to 83% (62/75). The area under the
ROC curve was 0.83.
Discussion
This is the first study to show that the single-item global
quality of life scale demonstrate evidence of the reliabil-
ity and validity for measuring the health status of adult
patients with cystic fibrosis. The single item global qual-
ity of life scale has the ability to distinguish between
adult CF patients with lower CF-QOL scores compared
from those with higher scores. The main potential
advantage of the single-item global quality of life scale
compared to other CF-QOL measures is its brevity and
applicability for use in routine clinical practice.
The interclass correlation coefficients for both the sin-
gle-item global quality and CF-QOL (0.78 and 0.83,










Figure 2 The distribution of the single-item score for 121 adult cystic fibrosis patients.
Table 1 Establishing the representativeness of the sample of 33 with repeat questionnaire information
Repeat questionnaire (N = 33) No repeat questionnaire (n = 88) p-value
Gender % male 48% 57% 0.54
Single item; mean(sd) 6.9 (1.8) 6.9 (2.0) 0.83
CF-QOL; mean(sd) 71.4 (14.3) 73.0 (16.4) 0.63
Age; mean (sd) 32.0 (10.1) 28.6 (8.2) 0.07
HAD anxiety; median (range) 6 (0 to 14) 5 (0 to 16) 0.24
HAD depression; median (range) 2 (0 to 11) 2 (0 to 13) 0.88
HAD = Hospital anxiety and depression scale
CF-QOL = Cystic fibrosis quality of life scale
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respectively) were very high (values greater than 0.75 are
excellent) as determined previously [13] showing high
reliability of the scales. The 95% confidence intervals for
the intra-class correlations are reasonably narrow. In
addition, there was little evidence of a biased group of
subjects with information on two sets of questionnaires.
Those subjects with repeat questionnaires had similar
QOL scores and HAD scores to those without repeat
questionnaires. They were slightly older (but only by an
average age of 3 years) and had a slightly lower percen-
tage of males.
The repeatability scores between measures over 2
weeks revealed that there was less variability of total
CF-QOL scores, 25% compared with 36% for the single
item global scale. This signifies that the disease-specific
CF-QOL scale with 9 domains was more stable com-
pared with the single-item global scale, which was simi-
lar finding that had been reported in other chronic
respiratory disease [14].
The sensitivity and specificity scores were relatively
high for both definitions of poor/good health using the
CF-QOL scale, showing that the single item quality of
life score was a reasonably accurate predictor of health
related quality of life.
There is no ‘gold standard’ outcome measure for
assessment of quality of life in adult cystic fibrosis
patients. However, there are valid disease-specific quality
Table 2 Correlation of single item quality of life with CF-
QOL, anxiety and depression, FEV1
CF-QOL scale Single item quality of life scale p-values
Physical functioning r = 0.46 < 0.001
Social functioning r = 0.51 < 0.001
Treatment issues r = 0.41 < 0.001
Chest symptoms r = 0.50 < 0.001
Emotional functioning r = 0.61 < 0.001
Concerns about the future r = 0.43 < 0.001
Interpersonal relationships r = 0.56 < 0.001
Body image r = 0.25 = 0.01
Carer concerns r = 0.53 < 0.001
Total QOL score r = 0.64 < 0.001
Anxiety r = -0.50 < 0.001
Depression r = -0.38 < 0.001
FEV1 r = 0.21 = 0.02
CF-QOL = Cystic fibrosis Quality of Life scale
FEV1 = Forced expiratory volume in one second
Figure 3 The sensitivity and specificity of the single-item global quality of life scale compared to a 50% threshold for the cystic
fibrosis quality of life scale. The single item global quality of life score predicts of the adult cystic fibrosis patients with the cystic fibrosis
quality of life score > 50. The receiver operating characteristic area was 84.
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of life scales for adult patients with cystic fibrosis [1,2].
The concurrent validity (a test against well-established
measures) of the single item scale was examined in rela-
tion to quality of life using the CF-QOL scale [1], psy-
chological well-being (anxiety and depression) [8] and
lung function tests. Findings demonstrated that the sin-
gle item global quality of life scale was moderately better
correlated with the some of the domains that are related
to psychosocial, physical functioning and chest symp-
toms, while in others it was weakly correlated with the
body image and lung function as reported in Table 2.
The potential reasons for these variations are unclear.
For instance, the weaker correlation between the single
item quality of life scale measure and body image may
suggest that adult patients with CF may have adopted a
level of negative image (stigma) of the disease in manner
that is different from an adaptation to physical function-
ing. This is in contrast to previous findings study [3]
that body image explained 30% of the variance in the
CF-QOL score. The association of frequent episodes of
hospital admission with impaired quality of life partly
may be explained that some of the adult CF patients
may experience frustration with the disease and inability
to cope at home in turn may lead them to social isola-
tion and poorer physical health status.
Our data is also in agreement with previous studies in
patients with chronic obstructive pulmonary disease
[5,14], the low correlation between FEV1 and the single
item quality of life scale value is partly may be explained
by the limited ability of FEV1 as a measure of disease
severity in CF [15]. However, the single item global scale
was moderately correlated with the anxiety and depression
scores. It may signify the importance of psychological
well-being for the individual patient and provide better
estimates of quality of life adult patients with cystic fibro-
sis. Further study is required to demonstrate the respon-
siveness of the scale to an intervention in a clinical setting.
Several limitations of the present study are note-
worthy. Firstly, the study was conducted in a single
referral centre in outpatient clinic in which the majority
of the patients were Caucasian. Thus, the generisability
of the findings to different demographics requires
further investigation. Due to the cross-sectional nature
of this study, we cannot hypothesize whether the single-
item global scale is responsive to change over time.
Further validation is required for the use of the scale for
Figure 4 The sensitivity and specificity of the single-item global quality of life scale compared to a 80% threshold for the cystic
fibrosis quality of life scale. The single item global quality of life score predicts of the adult patients with the cystic fibrosis quality of life score
> 80. The receiver operating characteristic area was 83.
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epidemiological or longitudinal surveys. Secondly, the
postal questionnaire has a disadvantage in terms of
uncertainty who completed the questionnaire (whether
it was completed by patients or carers). Less than one-
third of the CF patients responded to our postal ques-
tionnaire a poor response rate introducing the potential
for response bias i.e. motivated individuals may be more
likely to participate in this study. However, there was no
significant difference between those who responded and
those who did not respond in terms of socio-demo-
graphic characteristic data (Table 1). Furthermore, we
performed robust statistical tests for the scale validation
using the Interclass-correlation coefficient and the recei-
ver operating characteristic analyses. Finally, the relative
small sample size requires replication in a larger study.
In addition, the single-item global quality of life scale
provides clinicians with limited information about the
patient health status but acts as a screening tool. There-
fore, detailed investigation is most likely to be desirable
to those patients who responded low scores with the
single-item quality of life scale: ‘this must be balanced
against the practicality of ascertaining such information.
Brevity may come at a cost of detail.’ [16].
Clinical implication
We believe that the single item global scale is a promis-
ing tool that can be incorporated in clinical environments
to assess adult cystic fibrosis patients’ quality of life. It is
simple to administer in routine clinical practice in an
outpatient setting as it would not be burdensome (time-
consuming) for the adult cystic fibrosis patients to com-
plete. In addition, it will help to identify early those adult
cystic fibrosis patients with a ‘health status worsening’ in
order to provide and target appropriate intervention.
Conclusions
The single-item quality of scale is acceptable, valid and
repeatable for adult patients with cystic fibrosis. Further
studies are needed to fully validate the single-item qual-
ity of life scale in a larger sample size and assess its
responsiveness to interventions.
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